Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: MedTech Strategist October 2026

Philips' Jon Kamerman on the challenges of integrating AI solutions into the care continuum. FDA advisers back GRAIL's MCED panel but nuances complicate the market opportunity. How to measure the scalability of an AI medtech asset--not by accuracy. Vantiv aims to take its connected strategy beyond peritoneal dialysis to treating other vital organs. Recor Medical makes strides in securing coverage for its RDN system.

Read Article